Premera Blue Cross of Washington prior authorization, page 22

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
77438Surface radiation therapy; orthovoltage, delivery, >150-500 KV, per fractionClinical Review by Code List PBCWA, Pg 424 Original policy
77439Surface radiation therapy; superficial or orthovoltage, image guidance, ultrasound for placement of radiation therapy fields for treatment of cutaneous utmors, per course of treatment (list separately in additiona to code for primary procedure) These criteria do not imply or guarantee approval.Clinical Review by Code List PBCWA, Pg 424 Original policy
77469Intraoperative radiation treatment managementClinical Review by Code List PBCWA, Pg 425 Original policy
77470Special treatment procedure (eg, total body irradiation, hemibody radiation, per oral or endocavitary irradiation)Clinical Review by Code List PBCWA, Pg 425 Original policy
77520Proton treatment delivery; simple, without compensation These criteria do not imply or guarantee approval.Clinical Review by Code List PBCWA, Pg 425 Original policy
77522Proton treatment delivery; simple, with compensationClinical Review by Code List PBCWA, Pg 426 Original policy
77523Proton treatment delivery; intermediateClinical Review by Code List PBCWA, Pg 426 Original policy
77525Proton treatment delivery; complexClinical Review by Code List PBCWA, Pg 426 Original policy
77761Intracavitary radiation source application; simple These criteria do not imply or guarantee approval.Clinical Review by Code List PBCWA, Pg 426 Original policy
77762Intracavitary radiation source application; intermediateClinical Review by Code List PBCWA, Pg 427 Original policy
77763Intracavitary radiation source application; complexClinical Review by Code List PBCWA, Pg 427 Original policy
77767Remote afterloading high dose rate radionuclide skin surface brachytherapy, includes basic dosimetry, when performed; lesion diameter up to 2.0 cm or 1 channelClinical Review by Code List PBCWA, Pg 427 Original policy
77768Remote afterloading high dose rate radionuclide skin surface brachytherapy, includes basic dosimetry, when performed; lesion diameter over 2.0 cm and 2 or more channels, or multiple lesions These criteria do not imply or guarantee approval.Clinical Review by Code List PBCWA, Pg 427 Original policy
77770Remote afterloading high dose rate radionuclide interstitial or intracavitary brachytherapy, includes basic dosimetry, when performed; 1 channelClinical Review by Code List PBCWA, Pg 428 Original policy
77771Remote afterloading high dose rate radionuclide interstitial or intracavitary brachytherapy, includes basic dosimetry, when performed; 2-12 channelsClinical Review by Code List PBCWA, Pg 428 Original policy
77772Remote afterloading high dose rate radionuclide interstitial or intracavitary brachytherapy, includes basic dosimetry, when performed; over 12 channelsClinical Review by Code List PBCWA, Pg 428 Original policy
77778Interstitial radiation source application, complex, includes supervision, handling, loading of radiation source, when performed These criteria do not imply or guarantee approval.Clinical Review by Code List PBCWA, Pg 428 Original policy
77790Supervision, handling, loading of radiation sourceClinical Review by Code List PBCWA, Pg 429 Original policy
78429Myocardial imaging, positron emission tomography (pet), metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), single study; with concurrently acquired computed tomography transmission scanClinical Review by Code List PBCWA, Pg 430 Original policy
78430Myocardial imaging, positron emission tomography (pet), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); single study, at rest or stress (exercise or pharmacologic), with concurrently acquired computed tomography transmission scanClinical Review by Code List PBCWA, Pg 430 Original policy
78431Myocardial imaging, positron emission tomography (pet), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); multiple studies at rest and stress (exercise or pharmacologic), with concurrently acquired computed tomography transmission scanClinical Review by Code List PBCWA, Pg 430 Original policy
78432Myocardial imaging, positron emission tomography (pet), combined perfusion with metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), dual radiotracer (eg, myocardial viability) These criteria do not imply or guarantee approval.Clinical Review by Code List PBCWA, Pg 430 Original policy
78433Myocardial imaging, positron emission tomography (pet), combined perfusion with metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), dual radiotracer (eg, myocardial viability); with concurrently acquired computed tomography transmission scanClinical Review by Code List PBCWA, Pg 431 Original policy
78451Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); single study, at rest or stressClinical Review by Code List PBCWA, Pg 431 Original policy
78452Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stressClinical Review by Code List PBCWA, Pg 431 Original policy
78453Myocardial perfusion imaging, planar (including qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); single study, at rest or stress (exercise or pharmacologic) These criteria do not imply or guarantee approval.Clinical Review by Code List PBCWA, Pg 431 Original policy
78454Myocardial perfusion imaging, planar (including qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stressClinical Review by Code List PBCWA, Pg 432 Original policy
78459Myocardial imaging, positron emission tomography (PET), metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), single studyClinical Review by Code List PBCWA, Pg 432 Original policy
78466Myocardial imaging, infarct avid, planar; qualitative or quantitativeClinical Review by Code List PBCWA, Pg 432 Original policy
78468Myocardial imaging, infarct avid, planar; with ejection fraction by first pass techniqueClinical Review by Code List PBCWA, Pg 432 Original policy
78469Myocardial imaging, infarct avid, planar; tomographic SPECT with or without quantificationClinical Review by Code List PBCWA, Pg 432 Original policy
78472Cardiac blood pool imaging, gated equilibrium; planar, single study at rest or stress (exercise and/or pharmacologic), wall motion study plus ejection fraction, with or without additional quantitative processing These criteria do not imply or guarantee approval.Clinical Review by Code List PBCWA, Pg 432 Original policy
78473Cardiac blood pool imaging, gated equilibrium; multiple studies, wall motion study plus ejection fraction, at rest and stress (exercise and/or pharmacologic), with or without additional quantificationClinical Review by Code List PBCWA, Pg 433 Original policy
78481Cardiac blood pool imaging (planar), first pass technique; single study, at rest or with stress (exercise and/or pharmacologic), wall motion study plus ejection fraction, with or without quantificationClinical Review by Code List PBCWA, Pg 433 Original policy
78483Cardiac blood pool imaging (planar), first pass technique; multiple studies, at rest and with stress (exercise and/ or pharmacologic), wall motion study plus ejection fraction, with or without quantificationClinical Review by Code List PBCWA, Pg 433 Original policy
78491Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); single study, at rest or stress (exercise or pharmacologic)Clinical Review by Code List PBCWA, Pg 433 Original policy
78492Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); multiple studies at rest and stress (exercise or pharmacologic) These criteria do not imply or guarantee approval.Clinical Review by Code List PBCWA, Pg 433 Original policy
78494Cardiac blood pool imaging, gated equilibrium, SPECT, at rest, wall motion study plus ejection fraction, with or without quantitative processingClinical Review by Code List PBCWA, Pg 434 Original policy
78608Brain imaging, positron emission tomography (PET); metabolic evaluationClinical Review by Code List PBCWA, Pg 434 Original policy
78609Brain imaging, positron emission tomography (PET); perfusion evaluationClinical Review by Code List PBCWA, Pg 434 Original policy
78811Positron emission tomography (PET) imaging; limited area (eg, chest, head/neck)Clinical Review by Code List PBCWA, Pg 435 Original policy
78812Positron emission tomography (PET) imaging; skull base to mid-thighClinical Review by Code List PBCWA, Pg 435 Original policy
78813Positron emission tomography (PET) imaging; whole bodyClinical Review by Code List PBCWA, Pg 435 Original policy
78814Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; limited area (eg, chest, head/neck)Clinical Review by Code List PBCWA, Pg 435 Original policy
78815Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh These criteria do not imply or guarantee approval.Clinical Review by Code List PBCWA, Pg 435 Original policy
78816Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole bodyClinical Review by Code List PBCWA, Pg 436 Original policy
79445Radiopharmaceutical therapy, by intra- arterial particulate administrationClinical Review by Code List PBCWA, Pg 436 Original policy
81120IDH1 (isocitrate dehydrogenase 1 [NADP+], soluble) (eg, glioma), common variants (eg, R132H, R132C)Clinical Review by Code List PBCWA, Pg 437 Original policy
81121IDH2 (isocitrate dehydrogenase 2 [NADP+], mitochondrial) (eg, glioma), common variants (eg, R140W, R172M)Clinical Review by Code List PBCWA, Pg 437 Original policy
81161DMD (dystrophin) (eg, Duchenne/Becker muscular dystrophy) deletion analysis, and duplication analysis, if performedClinical Review by Code List PBCWA, Pg 437 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.